HRP20090411T1 - Suspenzijska formulacija feksofenadina - Google Patents

Suspenzijska formulacija feksofenadina Download PDF

Info

Publication number
HRP20090411T1
HRP20090411T1 HR20090411T HRP20090411T HRP20090411T1 HR P20090411 T1 HRP20090411 T1 HR P20090411T1 HR 20090411 T HR20090411 T HR 20090411T HR P20090411 T HRP20090411 T HR P20090411T HR P20090411 T1 HRP20090411 T1 HR P20090411T1
Authority
HR
Croatia
Prior art keywords
approximately
aqueous pharmaceutical
suspension according
pharmaceutical suspension
volume
Prior art date
Application number
HR20090411T
Other languages
English (en)
Croatian (hr)
Inventor
Agrawala Prafulla
Chrzan Kazimierz
Haribhakti Rajiv
Mermey Matthew
J. Porcello Curtis
Lee Silvey Gary
Tran Vinh
Original Assignee
Sanofi-Aventis U.S. Llc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=38120312&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=HRP20090411(T1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Sanofi-Aventis U.S. Llc filed Critical Sanofi-Aventis U.S. Llc
Publication of HRP20090411T1 publication Critical patent/HRP20090411T1/hr

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445—Non condensed piperidines, e.g. piperocaine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0087—Galenical forms not covered by A61K9/02 - A61K9/7023
    • A61K9/0095—Drinks; Beverages; Syrups; Compositions for reconstitution thereof, e.g. powders or tablets to be dispersed in a glass of water; Veterinary drenches
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Dispersion Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Pulmonology (AREA)
  • Immunology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
  • Saccharide Compounds (AREA)
HR20090411T 2005-12-14 2006-12-12 Suspenzijska formulacija feksofenadina HRP20090411T1 (hr)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US75030305P 2005-12-14 2005-12-14
PCT/US2006/047393 WO2007070517A2 (fr) 2005-12-14 2006-12-12 Suspension de fexofenadine

Publications (1)

Publication Number Publication Date
HRP20090411T1 true HRP20090411T1 (hr) 2010-01-31

Family

ID=38120312

Family Applications (1)

Application Number Title Priority Date Filing Date
HR20090411T HRP20090411T1 (hr) 2005-12-14 2006-12-12 Suspenzijska formulacija feksofenadina

Country Status (38)

Country Link
US (1) US8933097B2 (fr)
EP (1) EP1965768B1 (fr)
JP (1) JP5308824B2 (fr)
KR (1) KR101452792B1 (fr)
CN (1) CN101316580B (fr)
AR (1) AR058323A1 (fr)
AT (1) ATE431137T1 (fr)
AU (1) AU2006326551B2 (fr)
BR (1) BRPI0619895B1 (fr)
CA (1) CA2633086C (fr)
CR (1) CR9993A (fr)
CY (1) CY1109320T1 (fr)
DE (1) DE602006006870D1 (fr)
DK (1) DK1965768T3 (fr)
DO (1) DOP2006000274A (fr)
EC (1) ECSP088532A (fr)
EG (1) EG25866A (fr)
ES (1) ES2327168T3 (fr)
HN (1) HN2008000875A (fr)
HR (1) HRP20090411T1 (fr)
IL (1) IL192067A (fr)
JO (1) JO2549B1 (fr)
MA (1) MA30152B1 (fr)
MY (1) MY146988A (fr)
NO (1) NO339877B1 (fr)
NZ (1) NZ568943A (fr)
PE (1) PE20071003A1 (fr)
PL (1) PL1965768T3 (fr)
PT (1) PT1965768E (fr)
RS (1) RS51135B (fr)
RU (1) RU2405538C2 (fr)
SI (1) SI1965768T1 (fr)
TN (1) TNSN08186A1 (fr)
TW (1) TWI377061B (fr)
UA (1) UA89584C2 (fr)
UY (1) UY30021A1 (fr)
WO (1) WO2007070517A2 (fr)
ZA (1) ZA200803985B (fr)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR101546774B1 (ko) 2008-07-29 2015-08-24 엘지전자 주식회사 휴대 단말기 및 그 동작제어 방법
WO2013058996A1 (fr) 2011-10-19 2013-04-25 R.P. Scherer Technologies, Llc Système d'administration pharmaceutique à deux phases
JP6410814B2 (ja) 2013-07-01 2018-10-24 アベンティスユービー・エルエルシー フェキソフェナジンを含む経口投与用液体医薬組成物
CN105358138A (zh) * 2013-07-03 2016-02-24 R.P.谢勒技术有限公司 包含非索非那定的胶囊制剂
CN103610645B (zh) * 2013-11-25 2016-05-11 浙江万晟药业有限公司 一种非索非那定盐酸盐的药物组合物及制备方法
CN106806346B (zh) * 2015-12-01 2020-09-11 国药集团广东环球制药有限公司 一种非索非那定盐酸盐干混悬剂制剂及其制备方法
CN109906079B (zh) * 2016-06-16 2022-09-30 库蒂斯制药公司 用于质子泵抑制剂混悬剂的组合物和方法
JP7169671B2 (ja) 2017-06-02 2022-11-11 テイカ製薬株式会社 難水溶性成分可溶化ミセル及びそれを含有する液剤
US11633478B2 (en) 2019-07-16 2023-04-25 Azurity Pharmaceuticals, Inc. Compositions and kits for Omeprazole suspension
US10751333B1 (en) 2019-07-16 2020-08-25 Cutispharma, Inc. Compositions and kits for omeprazole suspension
WO2022038474A1 (fr) * 2020-08-18 2022-02-24 Innate S.R.L. Composition injectable et utilisation de ladite composition
WO2022175829A1 (fr) 2021-02-17 2022-08-25 Cellix Bio Private Limited Formulations et compositions topiques
US20250082623A1 (en) * 2021-12-29 2025-03-13 Opella Healthcare Group Sas Compositions containing fexofenadine
CN115715759B (zh) * 2022-11-03 2024-01-12 京海盛达(北京)科技有限公司 一种抗组胺混悬剂及其制备方法
CR20240566A (es) * 2023-01-20 2025-02-25 Opella Healthcare Group Sas Formulaciones de fexofenadina sin parabenos
WO2026074306A1 (fr) 2024-10-03 2026-04-09 Opella Healthcare Group Sas Comprimés de fexofénadine à mâcher

Family Cites Families (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4254129A (en) 1979-04-10 1981-03-03 Richardson-Merrell Inc. Piperidine derivatives
US4829064A (en) 1987-06-08 1989-05-09 Analgesic Associates Cough/cold mixtures comprising non-sedating antihistamine drugs
CA2449419C (fr) 1994-05-18 2011-09-06 Aventis Pharmaceuticals Inc. Methodes pour preparer des formes anhydres et hydratees de derives antihistaminiques de la piperidine; leurs formes polymorphes et pseudomorphes
US6132758A (en) 1998-06-01 2000-10-17 Schering Corporation Stabilized antihistamine syrup
US6319513B1 (en) * 1998-08-24 2001-11-20 The Procter & Gamble Company Oral liquid mucoadhesive compounds
GB9822170D0 (en) 1998-10-13 1998-12-02 Danbioyst Uk Ltd Novel formulations of fexofenadine
US20060083691A1 (en) * 2000-05-10 2006-04-20 Wermeling Daniel P Intranasal opioid compositions, delivery devices and methods of using same
DE60225694T2 (de) 2001-07-31 2008-06-26 Texcontor Etablissement Neues polymorph von fexo-fenadin
US6723348B2 (en) * 2001-11-16 2004-04-20 Ethypharm Orodispersible tablets containing fexofenadine
EP1587496B1 (fr) * 2003-01-30 2009-10-07 Ethypharm Particules presentant un enrobage de masquage du gout, procede de preparation associe et comprimes orodispersibles contenant lesdites particules enrobees
US20050250737A1 (en) * 2003-11-12 2005-11-10 Allergan, Inc. Therapeutic ophthalmic compositions containing retinal friendly excipients and related methods
US20050266031A1 (en) 2004-05-25 2005-12-01 Jay Dickerson Pharmaceutical suspension composition
DK2486942T3 (en) * 2004-11-24 2019-01-28 Meda Pharmaceuticals Inc COMPOSITIONS CONTAINING AZELASTINE AND PROCEDURES FOR USING IT
AU2006278874A1 (en) 2005-07-27 2007-02-15 Sandoz Ag A process for the preparation of substituted phenyl ether compounds and rosiglitazone
JP5133244B2 (ja) * 2005-08-05 2013-01-30 ルピン・リミテッド フェキソフェナジンの経口用医薬懸濁組成物

Also Published As

Publication number Publication date
NO339877B1 (no) 2017-02-13
EP1965768B1 (fr) 2009-05-13
AU2006326551B2 (en) 2012-06-07
JO2549B1 (en) 2010-09-05
MY146988A (en) 2012-10-15
JP2009519935A (ja) 2009-05-21
ZA200803985B (en) 2009-03-25
BRPI0619895A2 (pt) 2011-10-25
DE602006006870D1 (de) 2009-06-25
EG25866A (en) 2012-09-12
AR058323A1 (es) 2008-01-30
KR20080074180A (ko) 2008-08-12
CA2633086C (fr) 2011-10-18
HN2008000875A (es) 2012-01-30
JP5308824B2 (ja) 2013-10-09
WO2007070517A2 (fr) 2007-06-21
UY30021A1 (es) 2007-07-31
RS51135B (sr) 2010-10-31
NO20082904L (no) 2008-09-10
TWI377061B (en) 2012-11-21
CR9993A (es) 2008-09-23
PE20071003A1 (es) 2007-10-03
KR101452792B1 (ko) 2014-10-22
CN101316580A (zh) 2008-12-03
IL192067A0 (en) 2009-02-11
BRPI0619895B1 (pt) 2022-04-12
US8933097B2 (en) 2015-01-13
WO2007070517A3 (fr) 2007-08-23
UA89584C2 (en) 2010-02-10
ES2327168T3 (es) 2009-10-26
AU2006326551A1 (en) 2007-06-21
ECSP088532A (es) 2008-08-29
CA2633086A1 (fr) 2007-06-21
PT1965768E (pt) 2009-08-07
DOP2006000274A (es) 2007-10-15
NZ568943A (en) 2010-04-30
TNSN08186A1 (en) 2009-10-30
PL1965768T3 (pl) 2009-11-30
IL192067A (en) 2010-12-30
CY1109320T1 (el) 2014-07-02
ATE431137T1 (de) 2009-05-15
CN101316580B (zh) 2011-11-16
DK1965768T3 (da) 2009-09-07
US20080299211A1 (en) 2008-12-04
EP1965768A2 (fr) 2008-09-10
MA30152B1 (fr) 2009-01-02
TW200812581A (en) 2008-03-16
HK1123197A1 (en) 2009-06-12
RU2008128418A (ru) 2010-01-20
SI1965768T1 (sl) 2009-10-31
RU2405538C2 (ru) 2010-12-10

Similar Documents

Publication Publication Date Title
ES2262122T3 (es) Formulacion intranasal de rotigotina.
CN103052384B (zh) 包含溴己新的含水组合物
CA2668733C (fr) Preparation liquide comprenant un complexe de pimobendane et de cyclodextrine
RU2008128418A (ru) Композиция суспензии фексофенадина
HK1205933A1 (en) Enhanced stability phenylephrine liquid compositions
ES2277635T3 (es) Formulacion de disolucion solida oral de una sustancia activa escasamente soluble en agua.
JP2009519935A5 (fr)
WO2016159897A1 (fr) Suspension de citrate de potassium
CN102078285A (zh) 含有皮质激素和h1受体拮抗剂的鼻用原位凝胶
JP2590156B2 (ja) 経口投与用医薬組成物
WO2008015695A2 (fr) Complexe d'inclusion
ES2223595T3 (es) Composicion farmaceutica acuosa de contiene ciclesonida.
ES2781755T3 (es) Composición farmacéutica en forma de suspensión oral que comprende una fracción flavonoica y goma de xantano
HUE026162T2 (en) Olopatadine preparation for topical nasal administration
US20130129791A1 (en) Preparations of effervescent formulations comprising second and third generation cephalosporin and uses thereof
CA2518393A1 (fr) Composition pharmaceutique contenant de l'acide 5-methyl-2-2'-(chloro-6'-fluoroanilino)phenylacetique
PT92228B (pt) Processo para a preparacao de uma formulacao oral liquida, contendo diclofenac
CN102078612A (zh) 含有糠酸莫米松和h1受体拮抗剂的鼻用原位凝胶
ES2705238T3 (es) Composición de compuestos de tiacumicina
EP2515862A1 (fr) Formulation pharmaceutique à dispersion rapide contenant cefdinir
WO2011078828A1 (fr) Composition pharmaceutique très pure
TH92487A (th) การตั้งสูตรยาน้ำแขวนตะกอนของฟีโซฟีนาดีน
US5698562A (en) Palatable trimethoprim oral solution
JP3364453B2 (ja) センノシド含有水性液剤
KR100718211B1 (ko) 틱소코르톨 피발레이트 현탁액, 그를 기재로 한 함수제 및그를 함유하는 패키징